- Home
- CELZ vs KTTA Comparison
CELZ vs KTTA Comparison
Compare CELZ & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- KTTA
- Stock Information
- Founded
- CELZ 1998
- KTTA 2020
- Country
- CELZ United States
- KTTA United States
- Employees
- CELZ N/A
- KTTA N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- KTTA Health Care
- Exchange
- CELZ Nasdaq
- KTTA Nasdaq
- Market Cap
- CELZ 4.7M
- KTTA 4.5M
- IPO Year
- CELZ N/A
- KTTA 2021
- Fundamental
- Price
- CELZ $3.00
- KTTA $5.34
- Analyst Decision
- CELZ
- KTTA
- Analyst Count
- CELZ 0
- KTTA 0
- Target Price
- CELZ N/A
- KTTA N/A
- AVG Volume (30 Days)
- CELZ 11.1K
- KTTA 2.9M
- Earning Date
- CELZ 11-12-2024
- KTTA 11-11-2024
- Dividend Yield
- CELZ N/A
- KTTA N/A
- EPS Growth
- CELZ N/A
- KTTA N/A
- EPS
- CELZ N/A
- KTTA N/A
- Revenue
- CELZ $17,000.00
- KTTA N/A
- Revenue This Year
- CELZ N/A
- KTTA N/A
- Revenue Next Year
- CELZ N/A
- KTTA N/A
- P/E Ratio
- CELZ N/A
- KTTA N/A
- Revenue Growth
- CELZ N/A
- KTTA N/A
- 52 Week Low
- CELZ $2.65
- KTTA $3.61
- 52 Week High
- CELZ $10.28
- KTTA $17.40
- Technical
- Relative Strength Index (RSI)
- CELZ 44.19
- KTTA 55.24
- Support Level
- CELZ $2.94
- KTTA $4.60
- Resistance Level
- CELZ $3.15
- KTTA $7.50
- Average True Range (ATR)
- CELZ 0.22
- KTTA 0.82
- MACD
- CELZ -0.01
- KTTA 0.09
- Stochastic Oscillator
- CELZ 41.15
- KTTA 41.62
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.